Exosome Loaded Antibiotics for Bacterial Wound Infections
ID: DHA23C-002Type: Phase I
Overview

Topic

Exosome Loaded Antibiotics for Bacterial Wound Infections

Agency

Department of DefenseN/A

Program

Type: STTRPhase: Phase IYear: 2023

Topic Link

https://www.sbir.gov/node/2448117

Additional Information

https://www.defensesbirsttr.mil/
Timeline
  1. 1
    Release Aug 23, 2023 12:00 AM
  2. 2
    Open Sep 20, 2023 12:00 AM
  3. 3
    Next Submission Due Oct 18, 2023 12:00 AM
  4. 4
    Close Oct 18, 2023 12:00 AM
Description

The Department of Defense (DoD) is seeking proposals for the development of antibiotic-loaded exosomes for topical application on wounds for prophylaxis or adjunct treatment indications. The objective is to address the increasing mortality rates caused by multidrug-resistant bacterial infections in wounded patients. The topic focuses on the use of exosomes, nanoscale vesicles optimized for intercellular communication, to transport antibiotics to target cells and promote wound healing. The Phase I of the project will involve exosome formulation with a broad or narrow spectrum antibiotic, with a focus on reproducibility, scalability, and stability. Phase II will include pre-clinical evaluation of the antibiotic-loaded exosome using in vitro and animal wound models. The deliverable for this phase will be an antibiotic-loaded exosome that demonstrates safety and efficacy. Phase III will involve in vivo and human research to obtain FDA approval, with potential funding opportunities from various programs. The use of a topical antibiotic for ESKAPE pathogens would have immediate utility in both military and civilian settings. The solicitation is closed, and more information can be found on the DoD SBIR website.

Files
No associated files provided.
Similar Opportunities
DOD SBIR 24.4 Annual - Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for a Small Business Innovation Research (SBIR) program focused on the topic of "Sample Collection and Processing Methods to Support Battlefield Wound Infection Diagnostics (Direct to Phase II)". The Defense Health Agency is the branch responsible for this topic. The objective is to develop a simple-to-use sample collection and processing method capable of preparing an adequate specimen for the identification and accurate detection of specific fungal and/or bacterial species commonly associated with complex battlefield wound infections. The technology should be suitable for use in far-forward deployed environments. The current diagnostic capabilities for battlefield wound infections are limited and time-consuming, resulting in delays in treatment and medical intervention decisions. The proposed technology should enable rapid diagnosis (less than 2 hours) at the point of injury, improving patient outcomes and reducing morbidity and mortality. The technology should be compatible with wet/dry environments, require minimum logistical support, and be stable in long-term storage. It should also be easy to use with little training and provide unambiguous primary output. The technology must include a plan for FDA clearance and should align with CLIA-waived complexity standards. The SBIR program consists of three phases: Phase I focuses on demonstrating scientific and technical feasibility, Phase II involves refining the technology and integrating it with a rapid diagnostic platform, and Phase III aims to secure FDA approval and transition the technology for commercial use in both civilian and military settings. The proposal submission deadline is March 31, 2025. More information can be found on the grants.gov website or the DOD SBIR/STTR Opportunities page.
DOD SBIR 24.4 Annual - Dynamic Synthetic Tissues for Medical Simulation and Training
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of dynamic synthetic tissues for medical simulation and training. The objective is to create material-based solutions that can accurately demonstrate prolonged casualty care, nursing care, and trauma scenarios by dynamically changing the patient state based on the care being provided. The synthetic tissue materials should be capable of emulating real medical complications and demonstrate changes in appearance over time, providing learners with the correct sensory cues for treatment. The targeted material response areas include color change, texture change, swelling/edema, liquid secretion, smell production, and temperature control. The project will be conducted in two phases. Phase I will focus on the feasibility of developing synthetic materials capable of dynamic change over time. The proposer will demonstrate a functional prototype incorporating at least two of the objective capabilities mentioned above. Phase II will build upon the Phase I findings and prototype, aiming to develop a well-defined prototype that meets the requirements of the topic and can be made commercially viable. The Phase II prototype should include tissues surrounding the wounded area and demonstrate at least three of the identified requirements. The project duration for Phase II is two years, with a funding amount of $1.1 million. The end-state of the project is to provide training tools for combat medic schoolhouses, nursing providers, and surgical training providers. The transition and commercialization process in Phase III will involve building additional wounds and surrounding tissues based on feedback and results from Phase II. Overall, this solicitation seeks innovative research and development in the field of dynamic synthetic tissues for medical simulation and training, with the goal of improving training immersion, realism, and soldier buy-in while enabling new training scenarios in prolonged casualty care.
DOD SBIR 24.4 Annual - Innovative Solutions for Ethylene Oxide Mitigation Used in Sterilization Processes (Direct to Phase II)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for innovative solutions to mitigate ethylene oxide (ETO) used in sterilization processes. The goal is to promote environmentally friendly and sustainable practices in the field of sterilization technologies. ETO is commonly used in the manufacturing of medical devices for its effective sterilization properties, but its use raises environmental and health concerns due to its potential carcinogenicity. The DOD is specifically looking for advancements in sterilization technologies that prioritize environmental sustainability and health by minimizing or eliminating ethylene oxide emissions during medical device sterilization. The technology should be compatible with current ETO sterilization equipment and processes, and should not require significant alterations to existing setups. The proposal should include a plan for FDA clearance and EPA review, and the technology should be capable of operating continuously without becoming the rate-limiting step in current manufacturing processes. The Phase I of the project requires a feasibility study and documentation demonstrating the technical viability and strategic planning of the proposed solution. Phase II focuses on comprehensive development and refinement of the ETO byproduct mitigation solution, including prototype development, efficacy testing, regulatory compliance, and a scale-up strategy or commercialization plan. Following successful development, the technology has potential applications in various industries reliant on ETO sterilization, including medical, pharmaceutical, food, laboratory, veterinary, cosmetic, and textile sectors. The ultimate goal is to transition the ETO mitigation solution from development to widespread implementation across diverse industries, contributing to a safer and more sustainable future for medical device manufacturing. The proposal submission deadline is March 31, 2025. For more information, visit the DOD SBIR 24.4 Annual solicitation notice on grants.gov.
DOD SBIR 24.4 Annual - Medical Payloads for Army Robotic Platforms
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of medical payloads for Army robotic platforms. The objective is to create a modular medical mission payload that can carry heavy, climate-controlled containers to resupply blood and perform casualty evacuation (CASEVAC) with attachability to ground and air robotic/autonomous platforms. Currently, blood delivery, medical resupply, and CASEVAC are conducted by convoys of crewed vehicles, which can be limited in reaching the front line. The goal is to develop a medical multi-mission, modular payload that can be employed by robotic ground and air platforms. The payloads should comply with Safe Ride Standards for casualty evacuation using unmanned aerial vehicles (UAV), Robotics and Autonomous Systems, Ground (RAS-G), and modular payload design standards (Mod Payload). They should also be climate-controlled, collapsible, and capable of maintaining blood temperature between one and 10 degrees centigrade. The proposal should consider cost, and only Direct to Phase II (DP2) proposals will be accepted. The project duration includes Phase I, where a preliminary design of the payload should be formulated, Phase II, where the design is refined and a Technology Readiness Level (TRL) 5-6 system is created, and Phase III, which focuses on commercialization objectives. The solicitation is open until March 31, 2025. For more information, visit the [SBIR topic link](https://www.sbir.gov/node/2484469) or the [solicitation agency URL](https://www.defensesbirsttr.mil/SBIR-STTR/Opportunities/).
DOD SBIR 24.4 Annual - Medical Payloads for Army Robotic Platforms
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of medical payloads for Army robotic platforms. The objective is to create a modular medical mission payload that can carry heavy, climate-controlled containers to resupply blood and perform casualty evacuation (CASEVAC) with attachability to ground and air robotic/autonomous platforms. Currently, blood delivery, medical resupply, and CASEVAC are conducted by crewed vehicles, which can be challenging in reaching the front line. The goal is to develop a medical multi-mission, modular payload that can be employed by robotic ground and air platforms. The payloads should comply with Safe Ride Standards for casualty evacuation using unmanned aerial vehicles (UAV), Robotics and Autonomous Systems, Ground (RAS-G), and modular payload design standards (Mod Payload). They should also be climate-controlled, collapsible, and capable of maintaining blood temperature between one and 10 degrees centigrade. The proposal should consider cost, and only Direct to Phase II (DP2) proposals will be accepted. The Phase II deliverables include refining the preliminary design, creating a Technology Readiness Level (TRL) 5-6 modular medical mission payload, and demonstrating the payload's performance at a vendor-provided, government-approved location. Phase III involves pursuing commercialization objectives, developing a manufacturing-ready product design, and engaging in laboratory or operational testing. The keywords for this solicitation are UAS, UAV, Medical Payloads, Resupply, CASEVAC, and UGV. For more information, visit the DOD SBIR 24.4 Annual solicitation notice on grants.gov.